Compare Lustrum:STELLA PHARMA CORPORATION:4888

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index STELLA PHARMA CORPORATION Go to web site 4888 Medicals 東証グロース March 1, 2000 2021.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

STELLA PHARMA CORPORATION Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

STELLA PHARMA CORPORATION Balance Sheet 2025年3月期 STELLA PHARMA CORPORATION Balance Sheet 2024年3月期 STELLA PHARMA CORPORATION Balance Sheet 2023年3月期 STELLA PHARMA CORPORATION Balance Sheet 2022年3月期 STELLA PHARMA CORPORATION Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents
(Percent)
3,206up
(59.2%)up
2,053down
(53.7%)down
2,710down
(62.6%)down
3,276up
(69.4%)up
1,251
(61.1%)
Other Current AssetsHelp
(Percent)
2,037up
(37.6%)down
1,577up
(41.3%)up
1,082up
(25.0%)up
899up
(19.1%)down
560
(27.3%)
Tangible Fixed AssetsHelp
(Percent)
67down
(1.2%)down
82down
(2.1%)down
103up
(2.4%)up
92up
(2.0%)down
68
(3.3%)
Intangible Fixed AssetHelp
(Percent)
49down
(0.9%)down
53down
(1.4%)down
62down
(1.4%)down
68down
(1.5%)down
80
(3.9%)
Investments and OthersHelp
(Percent)
58up
(1.1%)down
57down
(1.5%)down
372down
(8.6%)up
383up
(8.1%)up
90
(4.4%)
Total AssetsHelp
(Percent)
5,417
(100%)
3,821
(100%)
4,329
(100%)
4,719
(100%)
2,049
(100%)
Total Current LiabilitiesHelp
(Percent)
1,601up
(29.6%)up
670up
(17.5%)up
643up
(14.9%)up
546down
(11.6%)down
564
(27.6%)
Total Long-term LiabilitiesHelp
(Percent)
608down
(11.2%)down
773down
(20.2%)down
933down
(21.6%)down
1,093down
(23.2%)down
1,253
(61.2%)
Shareholder's EquityHelp
(Percent)
3,207up
(59.2%)down
2,377down
(62.2%)down
2,753down
(63.6%)down
3,080up
(65.3%)up
231
(11.3%)
Total LiabilitiesHelp
(Percent)
5,417
(100%)
3,821
(100%)
4,329
(100%)
4,719
(100%)
2,049
(100%)

STELLA PHARMA CORPORATION Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

STELLA PHARMA CORPORATION Profit and Loss Account 2025年3月期 STELLA PHARMA CORPORATION Profit and Loss Account 2024年3月期 STELLA PHARMA CORPORATION Profit and Loss Account 2023年3月期 STELLA PHARMA CORPORATION Profit and Loss Account 2022年3月期 STELLA PHARMA CORPORATION Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales
(Percent)
961
(100%)
269
(100%)
229
(100%)
100
(100%)
206
(100%)
Total Sales
(Percent)
961
(100%)
269
(100%)
229
(100%)
100
(100%)
206
(100%)
Cost of SalesHelp
(Percent)
115up
(12.0%)down
52up
(19.4%)up
22up
(9.7%)down
15down
(15.2%)up
24
(11.7%)
Other Costs and RevenueHelp 987up
(102.7%)down
981down
(364.0%)down
986up
(430.3%)down
853up
(851.8%)up
841
(408.3%)
Total CostsHelp 1,102 1,033 1,008 868 865
Net RevenueHelp 846up
(88.0%)up
217up
(80.6%)down
207up
(90.3%)up
85down
(84.8%)down
182
(88.3%)
Earnings Before TaxHelp -138up
(-14.3%)up
-761up
(-282.4%)up
-776down
(-338.8%)up
-764down
(-763.4%)down
-656
(-318.7%)
Net IncomeHelp -141up
(-14.7%)up
-764up
(-283.4%)up
-779down
(-340.0%)up
-768down
(-767.0%)down
-659
(-320.1%)
当期純利益 -141 -764 -779 -768 -659

STELLA PHARMA CORPORATION Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

STELLA PHARMA CORPORATION Cash Flow Statement 2025年3月期 STELLA PHARMA CORPORATION Cash Flow Statement 2024年3月期 STELLA PHARMA CORPORATION Cash Flow Statement 2023年3月期 STELLA PHARMA CORPORATION Cash Flow Statement 2022年3月期 STELLA PHARMA CORPORATION Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help
(Percent)
140up
(12.2%)up
-877down
(-99.0%)down
-828up
(-96.5%)down
-1,081down
(-28.2%)up
-773
(-68.5%)
Investing Cash Flow(ICF)Help
(Percent)
288up
(25.0%)up
-9up
(-1.0%)up
-30up
(-3.5%)up
-351down
(-9.2%)down
-23
(-2.0%)
Financing Cash FlowHelp
(Percent)
721up
(62.8%)up
228down
(25.8%)down
292down
(34.0%)down
3,829up
(100.0%)up
-332
(-29.5%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0
-
-0
(0.0%)
0
-
0
-
0
-
Net Increase and Decrease in Cash and Cash Equivalentsn 1,149up
(100.0%)up
-657down
(-74.2%)down
-566down
(-66.0%)down
2,398up
(62.6%)up
-1,128
(-100.0%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

STELLA PHARMA CORPORATION

Company where related level is highHelp

STELLA PHARMA CORPORATION
Tsubota Laboratory Incorporated
NANO MRNA Co., Ltd.
Otsuka Holdings Co.,Ltd.
タウンズ
SymBio Pharmaceuticals Limited
ZERIA PHARMACEUTICAL CO.,LTD.
CanBas Co.,Ltd.
ASKA Pharmaceutical Co.,Ltd.
Kidswell Bio Corporation